Cases of respiratory syncytial virus (RSV), influenza, and COVID-19 in children, older adults, and other vulnerable populations are on the rise and warrant laboratory testing to inform treatment.
As respiratory viruses cocirculate this season, laboratory testing is increasingly essential to inform treatment of children, older adults, and other vulnerable populations.
The Fall 2022 edition of Magnify: The Art and Science of Diagnostic Medicine, shares how ARUP has applied what it learned from COVID-19 to improve operations, services, and, ultimately, patient care.
Benjamin Bradley, MD, PhD, is set to publish his first two virology articles on monkeypox testing protocols as ARUP Laboratories’ medical director of Virology and Molecular Infectious Diseases.
Benjamin Bradley, MD, PhD, joined ARUP’s team of medical directors amid the monkeypox outbreak. Now, his new research aims to help labs improve testing.
Ryan Metcalf, MD, CQA(ASQ), section chief of Transfusion Medicine at ARUP and University of Utah Health, at ARUP Blood Services, a collection site for an ARUP/University of Utah Health study to determine whether convalescent plasma is an effective treatment for COVID-19.
Based on data from 21,916 participants in 33 studies, the Association for the Advancement of Blood and Biotherapies (AABB) has issued guidelines for use of convalescent plasma in COVID-19 treatment.
In her lab at the University of Utah, Allison Carey, MD, PhD, is using a molecular barcoding approach she developed to identify the genes that allow some strains of Mycobacterium avium to establish chronic infections and resist treatment with antibiotics.
The National Institute of Allergy and Infectious Diseases has awarded Medical Director Allison Carey, MD, PhD, $1.5 million over five years to fund her groundbreaking research.
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in August.
ARUP Consult has released several new and updated resources for clinicians, including testing topics on kidney evaluation, gestational trophoblastic disease, and poliovirus.
The CDC recently confirmed the first U.S. case of polio since 2013, which has raised concerns about the virus. New ARUP Consult resources inform clinicians about lab testing for poliovirus.
Patricia Slev, PhD, section chief of Immunology at ARUP Laboratories, coauthored a newly published study that looked at COVID-19-related risks facing emergency department workers early in the pandemic.
A new study for which ARUP provided COVID-19 testing and expertise found that emergency department workers early in the pandemic faced the highest risk of infection from community spread.
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in July.
ARUP Consult, a free source of expert guidance in laboratory testing, offers valuable information on relevant topics from monkeypox to HLA testing and more.
ARUP has launched a new, in-house test to detect the DNA of orthopoxviruses, including monkeypox.
ARUP’s Dan Anderson will participate in a SmartBrief webinar on June 16 to share lessons learned from COVID-19 in an effort to help laboratories prepare for future pandemics.
As of May 23, multiple cases of monkeypox, a rare zoonotic infection endemic to Central and West African countries, had either been confirmed or were being investigated in at least six U.S. states.